Get it on Google Play

Mirum Pharmaceuticals to release Phase 3 hepatitis delta trial data

September 27, 2026 5:00 PM EDT Send to a Friend
Mirum Pharmaceuticals (NASDAQ: MIRM) announced it will host an investor call on September 28, 2026, to share ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login